Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Open, Randomised, Comparative, Multicentre Study of the Immunogenicity and Safety of M-M-R™II Manufactured With Recombinant Human Albumin (rHA) and VARIVAX® When Administered Concomitantly by Intramuscular (IM) Route or Subcutaneous (SC) Route at Two Separate Injection Sites in Healthy Subjects 12 to 18 Months of Age
Brief Summary: Primary objective:

To compare if, when given concomitantly with VARIVAX® by the same route at 12-18 months of age using separate injection sites, a single dose of M-M-RTMII administered by IM route is as immunogenic as a single dose of M-M-RTMII administered by SC route in terms of response rates to measles, mumps and rubella at 42 days following the vaccination.

AND/OR

To compare if, when given concomitantly with M-M-RTMII by the same route at 12-18 months of age using separate injection sites, a single dose of VARIVAX® administered by IM route is as immunogenic as a single dose of VARIVAX® administered by SC route in terms of response rate to varicella at 42 days following the vaccination

Secondary objectives:

* To summarise the antibody titres to measles, mumps, rubella and varicella at 42 days following the vaccination in children immunised with M-M-R™II and VARIVAX® administered concomitantly at two separate injection sites by the same route IM or SC,
* To evaluate the safety profiles of M-M-R™II and VARIVAX® administered concomitantly at two separate injection sites by the same route IM or SC.


Options:
A: Arm Label: Menhibrix A Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine, Biological: Pediarix, Biological: Prevnar, Biological: M-M-R II, Biological: Varivax | Arm Label: Menhibrix B Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine, Biological: Pediarix, Biological: Prevnar, Biological: M-M-R II, Biological: Varivax | Arm Label: Menhibrix C Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine, Biological: Pediarix, Biological: Prevnar, Biological: M-M-R II, Biological: Varivax | Arm Label: Menhibrix Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine, Biological: Pediarix, Biological: Prevnar, Biological: M-M-R II, Biological: Varivax | Arm Label: ActHIB Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: ActHIB, Biological: PedvaxHIB | Intervention Type: BIOLOGICAL; Name: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group | Intervention Type: BIOLOGICAL; Name: ActHIB; Assigned to Arm(s): ActHIB Group | Intervention Type: BIOLOGICAL; Name: PedvaxHIB; Assigned to Arm(s): ActHIB Group | Intervention Type: BIOLOGICAL; Name: Pediarix; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group | Intervention Type: BIOLOGICAL; Name: Prevnar; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group | Intervention Type: BIOLOGICAL; Name: M-M-R II; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group | Intervention Type: BIOLOGICAL; Name: Varivax; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group
B: Arm Label: GSK1437173A 18-30 Years Old Group; Type: EXPERIMENTAL; Interventions: Procedure: Blood sampling for assay of persistence of immunogenicity | Arm Label: GSK1437173A 50-70 Years Old Group; Type: EXPERIMENTAL; Interventions: Procedure: Blood sampling for assay of persistence of immunogenicity | Intervention Type: PROCEDURE; Name: Blood sampling for assay of persistence of immunogenicity; Assigned to Arm(s): GSK1437173A 18-30 Years Old Group, GSK1437173A 50-70 Years Old Group
C: Intervention Type: BIOLOGICAL; Name: MMRV; Assigned to Arm(s): N/A | Intervention Type: BIOLOGICAL; Name: MMR (Priorix®); Assigned to Arm(s): N/A | Intervention Type: BIOLOGICAL; Name: Varicella (Varilrix®); Assigned to Arm(s): N/A
D: Intervention Type: BIOLOGICAL; Name: M-M-R™II manufactured with recombinant Human Albumin (rHA) and VARIVAX®; Assigned to Arm(s): N/A

Answer: D